580
On 3/06/2008, a new orphan medicinal product was registered into the community register of orphan medicinal products under the EU orphan designation number 546. The active ingredient is Alpha-1 proteinase inhibitor (inhalation use) for treatment of congenital alpha-1 antitrypsin deficiency.